Mycophenolate Mofetil (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the Mycophenolate Mofetil drug offered from Cadila Healthcare Limited. This Antimetabolite Immunosuppressant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
NON-PROPRIETARY NAME: | Mycophenolate Mofetil |
SUBSTANCE NAME: | MYCOPHENOLATE MOFETIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antimetabolite Immunosuppressant [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2009-05-04 |
END MARKETING DATE: | 0000-00-00 |
Mycophenolate Mofetil HUMAN PRESCRIPTION DRUG Details:
Item Description | Mycophenolate Mofetil from Cadila Healthcare Limited |
LABELER NAME: | Cadila Healthcare Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 2009-05-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65841-680_45b6508d-c6c1-425f-aa62-97c15ed25a31 |
PRODUCT NDC: | 65841-680 |
APPLICATION NUMBER: | ANDA065433 |
Other MYCOPHENOLATE MOFETIL Pharmaceutical Manufacturers / Labelers: